Demystifying US Market Entry
How non-US life science companies can gain access to the US market
For many life science companies (and their agencies), entering the US market is essential to growth but equally, it can be a daunting prospect due to complex rules and regulatory requirements.
But help is at hand…
BioPortUSA is a US based business that helps non-US life science companies navigate the complex FDA regulatory approval process through to product launch in a cost effective and timely fashion.
In this special thenetworkone health and life agency member’s meeting, we are delighted to be hearing from Mark Lesselroth, CEO and President of BioPortUSA. Mark will explore the issues around US market entry for life science company with a focus on…
- A background to the US healthcare market
- Opportunities and challenges in US healthcare market
- The issues surrounding market entry for non-US life science businesses
- Strategies for achieving FDA approval
- Legal consideration
- How you can help your clients through this process
If you’d like to learn more – either for your agency or perhaps your clients, please reserve your place now!
Who Should Attend?
The content in Demistifying US Market Entry is designed for senior client facing people who work with international non-USA owned brands. Because the subject matter is quite specialist in nature, this will be a deliberately small and exclusive meeting of independent agencies who specialise in the health and life space.
Event Details
Healthcare Agencies Group Meeting
Demystifying US Market Entry
Time: 15.30 – 18.00
Location: Wallacespace, 22 Dukes Road, nr. Kings Cross, WC1H 9PN
Date: Monday 25th February
Cost: Free to thenetworkone members Presenter: Mark Lesselroth, CEO and President of BioPortUSA
Register via Eventbrite
